Genetic link found between the immune system and lymphoma

December 1, 2017, Institute of Cancer Research
Hodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0

People who inherit genetic changes which alter the function of their immune system are at increased risk of developing Hodgkin lymphoma, a major new study reports.

Scientists at The Institute of Cancer Research, London, identified six new that increase the risk of developing Hodgkin lymphoma - one of the most common cancers in young adults.

Many of the DNA changes seemed to affect the function of the immune system, and three had previously been associated with autoimmune diseases such as , rheumatoid arthritis or lupus.

The researchers stressed that the link did not mean people with autoimmune diseases are at increased risk of lymphoma, but did offer important genetic clues for understanding both lymphoma and autoimmune diseases better.

One of the genetic changes discovered increases the risk of Hodgkin lymphoma by more than a third and others by at least 15 per cent each - information that could point to new targeted drugs for the disease.

The study was published today in Nature Communications and was funded by a wide range of organisations including Bloodwise, Cancer Research UK and the Lymphoma Research Trust.

Scientists at The Institute of Cancer Research (ICR) analysed genetic data from 5,314 cases of Hodgkin lymphoma and 16,749 controls, from four different European studies.

The study is the largest of its kind for Hodgkin lymphoma. For most people, Hodgkin lymphoma can be successfully treated with first-line therapies - but there is a need for new treatments for those for whom first line treatment has failed.

The researchers identified six new single-letter changes in DNA that were linked to the development of Hodgkin lymphoma - and five of these affect the way a type of white blood cell, called B cells, develop.

Hodgkin lymphoma is a of the B cells - which are responsible for producing antibodies as a critical component of the immune system.

The study also picked out clear differences in genetic risk between two different subtypes of Hodgkin Lymphoma - nodular sclerosis Hodgkin Lymphoma (NSHL) and mixed cellularity Hodgkin Lymphoma (MCHL).

For example, a single-letter change located in DNA near the gene LPP increased the risk of NSHL by 37 per cent, but had little effect on the risk of developing MCHL.

Professor Richard Houlston, Professor of Molecular and Population Genetics at The Institute of Cancer Research, London, said:

"Hodgkin lymphoma is a cancer of immune cells called B cells, and our study links the risk of the disease to changes in the genes that control how B cells develop.

"Interestingly, we found that some of the genetic changes we have linked to Hodgkin lymphoma have previously been associated with the risk of such as multiple sclerosis and .

"It doesn't mean that if you develop an autoimmune disease you are at increased risk of lymphoma, but it does offer fascinating genetic clues to these diseases. The new information could point towards new ways of diagnosing, treating, or even helping to prevent Hodgkin lymphoma."

Professor Paul Workman, Chief Executive of The Institute of Cancer Research, London, said:

"Understanding the genetic changes that underpin cancer's development is crucial for all aspects of our quest to defeat cancer - to understand which patients are most at risk from different types of cancer, to improve diagnosis, and to develop treatments that are most likely to work for individual patients.

"This important new study sheds light on the DNA changes that can contribute to a person's risk of developing Hodgkin lymphoma, and offers clues as to how they might increase that risk, including the interesting link to the immune system. These findings could lead to new ways of managing the disease."

Dr Alasdair Rankin, Director of Research at Bloodwise said: "Because of research, treatments for many people with Hodgkin lymphoma are now good, and around 80 per cent of all people affected survive in the long-term. Although this is good news, treatments can have long-term health effects, such as infertility and secondary cancers, so finding kinder treatments for Hodgkin lymphoma is important. We welcome this study, which sheds new light on how Hodgkin develops."

Explore further: Having HIV and chronic HBV/HCV coinfection may increase cancer risk

Related Stories

Having HIV and chronic HBV/HCV coinfection may increase cancer risk

October 17, 2016
In HIV-infected patients receiving antiretroviral therapy (ART), chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) coinfection is associated with an increased risk for non-Hodgkin's lymphoma. The findings are published ...

ART era has changed secondary cancers after Kaposi sarcoma

August 25, 2017
(HealthDay)—There has been a significant decline in the risk of secondary cancers after Kaposi sarcoma (KS) in the era of highly-active antiretroviral therapy (HAART), according to a study published online Aug. 24 in JAMA ...

Hodgkin lymphoma survivors at high risk of second cancers

March 13, 2017
Patients who are cured of Hodgkin lymphoma are at a high risk of developing a second type of cancer, particularly if they have a family history of the disease, a major new study reports.

Scientists identify genetic drivers of common lymphoma

October 31, 2017
An international team of scientists has pinpointed the genetic drivers of diffuse large B-cell lymphoma—the most common type of blood cancer—and determined the genes' clinical significance. The study, published in the ...

Second cancer risk persists for Hodgkin's lymphoma survivors

December 29, 2015
(HealthDay)—Hodgkin's lymphoma survivors have an increased risk of a second cancer, with risk still elevated at 35 years or more after treatment, according to a study published in the Dec. 24 issue of the New England Journal ...

Pregnancy does not increase risk of Hodgkin lymphoma recurrence

December 15, 2015
Pregnancy does not increase the risk of relapse among women successfully treated for Hodgkin lymphoma. This according to a new study from Sweden's Karolinska Institutet and Uppsala University published in The Journal of Clinical ...

Recommended for you

Student develops microfluidics device to help scientists identify early genetic markers of cancer

October 16, 2018
As anyone who has played "Where's Waldo" knows, searching for a single item in a landscape filled with a mélange of characters and objects can be a challenge. Chrissy O'Keefe, a Ph.D. student in the Department of Biomedical ...

Technique to 'listen' to a patient's brain during tumour surgery

October 16, 2018
Surgeons could soon eavesdrop on a patient's brain activity during surgery to remove their brain tumour, helping improve the accuracy of the operation and reduce the risk of impairing brain function.

Researchers elucidate roles of TP63 and SOX2 in squamous cell cancer progression

October 16, 2018
Squamous cell carcinomas (SCCs) are aggressive malignancies arising from the squamous epithelium of various organs, such as the esophagus, head and neck, lungs, and skin. Previous studies have demonstrated that two master ...

Function of neutrophils during tumor progression unraveled

October 15, 2018
Researchers at The Wistar Institute have characterized the function of neutrophils, a type of white blood cells, during early stages of tumor progression, showing that they migrate from the bone marrow to distant sites and ...

Delving where few others have gone, leukemia researchers open new path

October 15, 2018
A Wilmot Cancer Institute study uncovers how a single gene could be at fault in acute myeloid leukemia (AML), one of the deadliest cancers. The breakthrough gives researchers renewed hope that a gene-targeted therapy could ...

3-D mammography detected 34% more breast cancers in screening

October 15, 2018
In traditional mammography screening, all breast tissue is captured in a single image. Breast tomosynthesis, on the other hand, is three-dimensional and works according to the same principle as what is known as tomography. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.